Clinical Trials Directory

Trials / Completed

CompletedNCT05557149

Virtual Reality Exposure and Respiratory Relaxation-Based Coping With Cocaine Craving in Cocaine Users

Development and Evaluation of a Virtual Reality Application for Eliciting Craving and Its Physiological Arousal in Cocaine Users

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Laboratoire de Psychologie des Cognitions · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Our study main objective is to test whether virtual reality exposure could elicit cocaine craving and its physiological arousal in cocaine users. Investigators aim to compare self-reported cocaine craving, self-efficacy to cope with craving and emotional states levels in 11 voluntary and adults cocaine users in 3 consecutive 10-mins conditions: Neutral VR (virtual reality exposure to neutral stimuli), Cocaine VR (virtual reality exposure to cocaine use-related stimuli) and Relaxation (respiratory relaxation).

Conditions

Interventions

TypeNameDescription
DEVICEVirtual Reality Exposure to Neutral CuesVirtual reality exposure to neutral stimuli (360 degrees visual and audio immersion with Oculus Quest 2 virtual reality headset). Participants stay sitted on chair and can tilt, rotate and move forward and backward upper body members. No interaction with the investigator during the virtual reality immersion.
BEHAVIORALRespiratory RelaxationRespiratory relaxation practise. No interaction with the investigator during the relaxation practise.
DEVICEVirtual Reality Exposure to Cocaine-Related CuesVirtual reality exposure to cocaine-related stimuli (360 degrees visual and audio immersion with Oculus Quest 2 virtual reality headset). Participants stay sitted on chair and can tilt, rotate and move forward and backward upper body members. No interaction with the investigator during the virtual reality immersion.

Timeline

Start date
2021-03-31
Primary completion
2021-07-29
Completion
2021-07-29
First posted
2022-09-27
Last updated
2022-09-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05557149. Inclusion in this directory is not an endorsement.